Cerebral venous thrombosis: When etiology makes the difference;Trombosis venosa cerebral: Cuando la etiología marca la diferencia

Neurologia

Volumn 24, Issue 7, 2009, Pages 439-445

  Alonso Canovas A ^a   Masjuan, J ^a   Gonzalez Valcarcel J ^a   Matute Lozano, M C ^a   Garcia Caldentey J ^a   Alonso Arias, M A ^a   Garcia Avello A ^b  

^a Unidad de Ictus   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Cerebral vein and sinus thrombosis; Etiology; Prognosis; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; STEROID;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN TUMOR; BRAIN VEIN; CEREBRAL SINUS THROMBOSIS; CONTROLLED STUDY; CRANIECTOMY; DECOMPRESSION SURGERY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HUMAN; INTRACRANIAL HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; PROTEIN C DEFICIENCY; RANKIN SCALE; SEIZURE; SUPERIOR SAGITTAL SINUS; SURGICAL DRAINAGE; THROMBOPHILIA; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM INFECTIONS; CEREBRAL VEINS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HUMANS; INTRACRANIAL THROMBOSIS; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 72949095322     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol 2007;6:162-170
2. Stam J. Current concepts: thrombosis of the cerebral veins and sinuses. N Engl J Med 2005;352:1791-1798
3. Ferro JM, Correia M, Rosas MJ, Pinto AN, Neves G. Cerebral Venous Thrombosis Portuguese Collaborative Study Group [Venoport]. Seizures in cerebral vein and dural sinus thrombosis. Cerebrovasc Dis 2003;15:78-83.
4. Petzold A, Smith M. High intracranial pressure brain herniation and death in cerebral venous thrombosis. Stroke 2006;37:331-332 (Pubitemid 43731961)
5. Selim M, Fink J, Linfante I, Kumar S, Schlaug G, Caplan LR. Diagnosis of cerebral venous thrombosis with echo-planar T2*SW-weighted magnetic resonance imaging. Arch Neurol 2002;59:1021-1026
6. Stam J, De Bruijn SF, DeVeber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev 2002;4:CD002005-CD002005.
7. Einhäupl K, Bousser MG, de Bruijn SF, Ferro JM, Martinelli I, Masuhr F, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol 2006;13:553-559
8. Ciccone A, Canhão P, Falcão F, Ferro JM, Sterzi R. Thrombolysis for cerebral vein and dural sinus thrombosis. Cochrane Database Syst Rev 2004;(1): CD003693.
9. Newman CB, Pakbaz RS, Nguyen AD, Kerber CW. Endovascular treatment of extensive cerebral sinus thrombosis. J Neurosurg 2009;110:442-445
10. Ventura P, Cobelli M, Marietta M, Panini R, Rosa MC, Salvioli G. Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor V Leyden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis. Cerebrovasc Dis 2004;17:153-159 (Pubitemid 38529191)
11. Prandoni P. Acquired risk factors for venous thromboembolism in medical patients. Hematology Am Soc Hematol Educ Program 2005;458-461
12. Luyendyk JP, Tilley RE, Mackman N. Genetic susceptibility to thrombosis. Curr Atheroscler Rep 2006;8:193-197
13. Reuner KH, Jenetzky E, Aleu A, Litfin F, Mellado P, Kloss M, et al. Factor XII C46T gene polymorphism and the risk of cerebral venous thrombosis. Neurology 2008;70:129-132
14. Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke 1988;19:1497-1500
15. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35:664-670
16. Graus F. Bilateral hemorrhagic infarction caused by tumoral thrombosis of the superior longitudinal sinus. Neurología 1997;12:372-373
17. Martin Polo J, Rivas López T, Martín Polo R, Ortin Castaño A, Arcaya Navarro J, Cacho Gutiérrez J. Cavernous sinus syndrome: an initial expression of a breast carcinoma. Neurología 2005;20:153-155 (Pubitemid 40592982)
18. Bernal-Rodríguez R, Simón de las Heras R, Mateos-Beato F, Muñoz-González A. Trombosis venosa intracraneal: a propósito de 11 casos pediátricos. Rev Neurol 2008;46: 273-279
19. González-Hernández A, Fabre-Pi O, López- Fernández JC, Araña-Toledo V, López-Veloso C, Suárez-Muñoz J. Prevalencia de los trastornos de la coagulación en una serie de trombosis de senos venosos cerebrales. Rev Neurol 2007;45:661-664
20. Álvarez-Pérez FJ, García-Sancho C, Zunzunegui-Costas J, López-Facal M, Marín-Sánchez M, Rey del Corral P. Trombosis venosa intracraneal: estudio de 16 casos y revisión de la bibliografía. Rev Neurol 2001;33:505-510
21. Saw VPJ, Kollar C, Johnston IH. Dural sinus thrombosis: a mechanism based classification and review of 42 cases. J Clin Neurosci 1999;6:480-487
22. Wasay M, Bakshi R, Bobustuc G, Kojan S, Sheikh Z, Dai A, et al. Cerebral Venous Thrombosis: Analysis of a Multicenter Cohort from the United States. J Stroke Cerebrovasc Dis 2008;17:49-54.
23. Ferro JM, Correia M, Pontes C, Baptista MV, Pita F; Cerebral Venous Thrombosis Portuguese Collaborative Study Group (Venoport). Cerebral vein and dural sinus thrombosis in Portugal: 1980-1998. Cerebrovasc Dis 2001;11:177-182
24. Damak M, Crassard I, Wolff V, Bousser MG. Isolated lateral sinus thrombosis. A series of 62 patients. Stroke 2009;40:476-481
25. de Bruijn SF, de Haan RJ, Stam J. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. J Neurol Neurosurg Psychiatry 2001;70:105-108 (Pubitemid 32096130)
26. Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F, ISCVT Investigators. Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke 2008;39:1152-1158
27. Ferro JM, Lopes MG, Rosas MJ, Ferro MA, Fontes J; Cerebral Venous Thrombosis Portuguese Collaborative Study Group. Long-term prognosis of cerebral vein and dural sinus thrombosis: results of the VENOPORT study. Cerebrovasc Dis 2002;13:272-278
28. Girot M, Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, et al. Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke 2007;38:337-342
29. Gosk-Bierska I, Wysokinski W, Brown RD Jr, Karnicki K, Grill D, Wiste H, et al. Cerebral venous sinus thrombosis: Incidence of venous thrombosis recurrence and survival. Neurology 2006;67:814-819
30. Preter M, Tzourio C, Ameri A, Bousser MG. Long-term Prognosis in Cerebral Venous Thrombosis. Follow-up of 77 patients. Stroke 1996;27:243-246
31. Wysokinska EM, Wysokinski WE, Brown RD, Karnicki K, Gosk-Beirska I, Grill D, et al. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. Neurology 2008;70:627-633 (Pubitemid 351294640)
32. Verdelho A, Ferro JM, Palmeiro A, Antunes C. Cerebral venous thrombosis and familial prothrombin gene G20210a mutation. Rev Neurol 2001;33:335-338
33. Masjuan J, Pardo J, Callejo JM, Andrés MT, Álvarez- Cermeño JC. Tamoxifen: a new risk factor for cerebral sinus thrombosis. Neurology 2004;62:334-335 (Pubitemid 38167157)
34. Grisold W, Oberndorfer S, Struhal W. Stroke and cancer: a review. Acta Neurol Scand 2009;119:1-16.